SLC5A2 and endothelial dysfunction: Certain therapies such as statins, ACE-Is, ARNI, SGLT2-is, and GLP-1RAs demonstrated a potential beneficial effect on endothelial dysfunction, reversing this pathogenic substrate and improving CMD and ACM manifestations.